Dystonia is a neurological movement disorder characterized by involuntary muscle contractions that cause repetitive movements or abnormal postures. It can affect a single body region or multiple areas, leading to significant functional impairment and pain. Dystonia arises from disruptions in the basal ganglia and sensorimotor integration, often linked to genetic mutations, brain injury, or pharmacologic triggers.

The Dystonia session investigates the complex neurophysiology and clinical spectrum of dystonic syndromes, from focal cervical dystonia to generalized and task-specific forms. Researchers are decoding altered inhibitory control, maladaptive plasticity, and neurotransmitter imbalance underlying abnormal muscle activity.

At the Dystonia Research Conference, clinicians and scientists share updates on molecular genetics, electrophysiology, and neuromodulation therapies. Emerging imaging studies reveal how abnormal connectivity between motor cortex, thalamus, and cerebellum contributes to dystonia’s pathogenesis.

This session is essential for neurologists, physiatrists, and movement-disorder specialists exploring modern interventions. It emphasizes botulinum-toxin therapy, deep-brain stimulation, physical rehabilitation, and neurofeedback as multimodal treatment strategies.

Findings from Movement Disorders research continue to redefine dystonia, promoting early diagnosis and personalized approaches to restoring motor control and quality of life.